| UniProt ID | AVIL_HUMAN | |
|---|---|---|
| UniProt AC | O75366 | |
| Protein Name | Advillin | |
| Gene Name | AVIL | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 819 | |
| Subcellular Localization | Cytoplasm, cytoskeleton. Cell projection. Cell projection, axon. | |
| Protein Description | Ca(2+)-regulated actin-binding protein. May have a unique function in the morphogenesis of neuronal cells which form ganglia. Required for SREC1-mediated regulation of neurite-like outgrowth. Plays a role in regenerative sensory axon outgrowth and remodeling processes after peripheral injury in neonates. Involved in the formation of long fine actin-containing filopodia-like structures in fibroblast. Plays a role in ciliogenesis.. | |
| Protein Sequence | MPLTSAFRAVDNDPGIIVWRIEKMELALVPVSAHGNFYEGDCYVILSTRRVASLLSQDIHFWIGKDSSQDEQSCAAIYTTQLDDYLGGSPVQHREVQYHESDTFRGYFKQGIIYKQGGVASGMKHVETNTYDVKRLLHVKGKRNIRATEVEMSWDSFNRGDVFLLDLGKVIIQWNGPESNSGERLKAMLLAKDIRDRERGGRAKIGVIEGDKEAASPELMKVLQDTLGRRSIIKPTVPDEIIDQKQKSTIMLYHISDSAGQLAVTEVATRPLVQDLLNHDDCYILDQSGTKIYVWKGKGATKAEKQAAMSKALGFIKMKSYPSSTNVETVNDGAESAMFKQLFQKWSVKDQTMGLGKTFSIGKIAKVFQDKFDVTLLHTKPEVAAQERMVDDGNGKVEVWRIENLELVPVEYQWYGFFYGGDCYLVLYTYEVNGKPHHILYIWQGRHASQDELAASAYQAVEVDRQFDGAAVQVRVRMGTEPRHFMAIFKGKLVIFEGGTSRKGNAEPDPPVRLFQIHGNDKSNTKAVEVPAFASSLNSNDVFLLRTQAEHYLWYGKGSSGDERAMAKELASLLCDGSENTVAEGQEPAEFWDLLGGKTPYANDKRLQQEILDVQSRLFECSNKTGQFVVTEITDFTQDDLNPTDVMLLDTWDQVFLWIGAEANATEKESALATAQQYLHTHPSGRDPDTPILIIKQGFEPPIFTGWFLAWDPNIWSAGKTYEQLKEELGDAAAIMRITADMKNATLSLNSNDSEPKYYPIAVLLKNQNQELPEDVNPAKKENYLSEQDFVSVFGITRGQFAALPGWKQLQMKKEKGLF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 (in isoform 2) | Phosphorylation | - | 44.33 | 24043423 | |
| 3 (in isoform 2) | Phosphorylation | - | 5.96 | 24043423 | |
| 4 (in isoform 2) | Phosphorylation | - | 16.49 | 24043423 | |
| 4 | Phosphorylation | ----MPLTSAFRAVD ----CCCCCCCCCCC | 16.49 | 23663014 | |
| 5 | Phosphorylation | ---MPLTSAFRAVDN ---CCCCCCCCCCCC | 32.85 | 23663014 | |
| 9 (in isoform 2) | Phosphorylation | - | 13.43 | 24043423 | |
| 10 (in isoform 2) | Phosphorylation | - | 6.52 | 24043423 | |
| 53 | Phosphorylation | LSTRRVASLLSQDIH EEHHHHHHHHHCCEE | 27.30 | - | |
| 85 | Phosphorylation | YTTQLDDYLGGSPVQ EEECHHHHCCCCCCC | 13.60 | - | |
| 107 | Phosphorylation | ESDTFRGYFKQGIIY CCCCCHHHCCCCEEE | 11.89 | 26074081 | |
| 114 | Phosphorylation | YFKQGIIYKQGGVAS HCCCCEEEEECCCCC | 8.71 | 26074081 | |
| 121 | Phosphorylation | YKQGGVASGMKHVET EEECCCCCCCEEEEC | 36.69 | 26074081 | |
| 124 | Acetylation | GGVASGMKHVETNTY CCCCCCCEEEECCCC | 48.28 | 19827443 | |
| 128 | Phosphorylation | SGMKHVETNTYDVKR CCCEEEECCCCCHHH | 31.60 | 26074081 | |
| 130 | Phosphorylation | MKHVETNTYDVKRLL CEEEECCCCCHHHHH | 28.63 | 26074081 | |
| 131 | Phosphorylation | KHVETNTYDVKRLLH EEEECCCCCHHHHHC | 22.32 | 26074081 | |
| 216 | Phosphorylation | EGDKEAASPELMKVL ECCHHHCCHHHHHHH | 26.42 | - | |
| 231 | Phosphorylation | QDTLGRRSIIKPTVP HHHHCCCCCCCCCCC | 27.57 | 24719451 | |
| 248 | Phosphorylation | IIDQKQKSTIMLYHI HCCCCCCCEEEEEEE | 22.22 | 26471730 | |
| 249 | Phosphorylation | IDQKQKSTIMLYHIS CCCCCCCEEEEEEEE | 19.90 | 26471730 | |
| 253 | Phosphorylation | QKSTIMLYHISDSAG CCCEEEEEEEECCCC | 4.63 | 26471730 | |
| 256 | Phosphorylation | TIMLYHISDSAGQLA EEEEEEEECCCCCEE | 16.52 | 26471730 | |
| 258 | Phosphorylation | MLYHISDSAGQLAVT EEEEEECCCCCEEEE | 27.75 | 26471730 | |
| 296 | Acetylation | GTKIYVWKGKGATKA CCEEEEEECCCCCHH | 40.47 | 12654405 | |
| 310 | Phosphorylation | AEKQAAMSKALGFIK HHHHHHHHHHHCCEE | 15.28 | - | |
| 319 | Methylation | ALGFIKMKSYPSSTN HHCCEEECCCCCCCC | 41.66 | - | |
| 320 | Phosphorylation | LGFIKMKSYPSSTNV HCCEEECCCCCCCCC | 38.48 | - | |
| 329 | Phosphorylation | PSSTNVETVNDGAES CCCCCCEECCCHHHH | 21.96 | - | |
| 336 | Phosphorylation | TVNDGAESAMFKQLF ECCCHHHHHHHHHHH | 25.21 | - | |
| 426 | Ubiquitination | YGGDCYLVLYTYEVN ECCEEEEEEEEEEEC | 1.23 | 21963094 | |
| 444 | Ubiquitination | HHILYIWQGRHASQD EEEEEEECCCCCCHH | 29.50 | 21963094 | |
| 616 | Phosphorylation | QEILDVQSRLFECSN HHHHHHHHHHHHHCC | 30.69 | 19413330 | |
| 720 | Ubiquitination | PNIWSAGKTYEQLKE CCHHHCCHHHHHHHH | 47.88 | 21963094 | |
| 743 | Ubiquitination | MRITADMKNATLSLN HHHEEECCCCEEECC | 43.93 | 21963094 | |
| 754 | Phosphorylation | LSLNSNDSEPKYYPI EECCCCCCCCCCCEE | 61.11 | 24719451 | |
| 758 | Phosphorylation | SNDSEPKYYPIAVLL CCCCCCCCCEEEEEE | 25.78 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AVIL_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AVIL_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AVIL_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DDX11_HUMAN | DDX11 | physical | 28514442 | |
| DUS3L_HUMAN | DUS3L | physical | 28514442 | |
| FIGL1_HUMAN | FIGNL1 | physical | 28514442 | |
| SCYL1_HUMAN | SCYL1 | physical | 28514442 | |
| DOCK7_HUMAN | DOCK7 | physical | 28514442 | |
| VILI_HUMAN | VIL1 | physical | 28514442 | |
| TMOD2_HUMAN | TMOD2 | physical | 28514442 | |
| RICTR_HUMAN | RICTOR | physical | 28514442 | |
| DCTN6_HUMAN | DCTN6 | physical | 28514442 | |
| MCM8_HUMAN | MCM8 | physical | 28514442 | |
| THUM3_HUMAN | THUMPD3 | physical | 28514442 | |
| FANCJ_HUMAN | BRIP1 | physical | 28514442 | |
| MYO5C_HUMAN | MYO5C | physical | 28514442 | |
| ALMS1_HUMAN | ALMS1 | physical | 28514442 | |
| MYO1F_HUMAN | MYO1F | physical | 28514442 | |
| TBA4A_HUMAN | TUBA4A | physical | 28514442 | |
| TBB8_HUMAN | TUBB8 | physical | 28514442 | |
| MYO1B_HUMAN | MYO1B | physical | 28514442 | |
| MYO5A_HUMAN | MYO5A | physical | 28514442 | |
| UBP47_HUMAN | USP47 | physical | 28514442 | |
| CN080_HUMAN | C14orf80 | physical | 28514442 | |
| TBB3_HUMAN | TUBB3 | physical | 28514442 | |
| WDR59_HUMAN | WDR59 | physical | 28514442 | |
| BBS1_HUMAN | BBS1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, AND MASSSPECTROMETRY. | |